Saganuwan Saganuwan A
Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, Federal University of Agriculture, P.M.B. 2373, Makurdi, Benue State, Nigeria.
Cent Nerv Syst Agents Med Chem. 2020;20(1):3-12. doi: 10.2174/1871524919666190621160323.
Benzimidazole (albendazole), imidazothiazole (levamisole) and imidazole (euconazole) are used in chemotherapy of helminthosis and mycosis respectively, with central nervous system (CNS) side effects. But only a limited number of azole groups are used clinically in the treatment of CNS diseases, which are on increase and could not be cured permanently. Due to increased incidence of more challenging new CNS diseases, there is a need for the synthesis of more potent CNS drugs.
Hence, literature studies were carried out for the identification of common pathways for the synthesis of the three groups of compounds, their CNS properties and the possibility of modifying them to potent CNS drugs.
Findings have shown that gloxal with formaldehyde in the presence of ammonia can be converted into imidazole, imidazothiazole and benzimidazole via distillation, condensation, alkylation, acylation, oxidation, cyclization, sulphation and amidation. However, agents such as phosphorus pentoxide, ethanolic potassium hydroxide, sodium hypochlorite, sodium hexafluroaluminate, aniline, calcium acetate, calcium benzoate, sodium hydroxide, aromatic aldehydes, bromoketones, alpha dicarbonyl compounds among others are used as reagents. The furan ring(s) may have a strong capability of penetrating CNS for the treatment of neurological disorders. The products from the three groups have agonistic, antagonistic, mixed agonistic and mixed antagonistic depressant and stimulant activities due to the presence of heteroatoms such as nitrogen, oxygen and sulphur. Imidazole may be the most potent with best characteristics of CNS penetrability and activity followed by imidazothiazole and benzimidazole.
Azole group is common to all the three classes and may be responsible for some of their CNS effects. The resultant compounds could act via all neurotransmitters, voltage and ligand-gated ion channels and may be chiral.
苯并咪唑(阿苯达唑)、咪唑并噻唑(左旋咪唑)和咪唑(益康唑)分别用于蠕虫病和真菌病的化疗,均有中枢神经系统(CNS)副作用。但临床上仅有限数量的唑类用于中枢神经系统疾病的治疗,而此类疾病正在增加且无法永久治愈。由于更具挑战性的新型中枢神经系统疾病发病率上升,需要合成更有效的中枢神经系统药物。
因此,开展文献研究以确定这三类化合物的合成通用途径、它们的中枢神经系统特性以及将它们修饰为有效中枢神经系统药物的可能性。
研究结果表明,乙二醛与甲醛在氨存在下可通过蒸馏、缩合、烷基化、酰化、氧化、环化、硫酸化和酰胺化转化为咪唑、咪唑并噻唑和苯并咪唑。然而,诸如五氧化二磷、乙醇氢氧化钾、次氯酸钠、六氟铝酸钠、苯胺、醋酸钙、苯甲酸钙、氢氧化钠、芳香醛、溴代酮、α - 二羰基化合物等试剂也被使用。呋喃环可能具有很强的穿透中枢神经系统治疗神经疾病的能力。由于存在氮、氧和硫等杂原子,这三类产物具有激动、拮抗、混合激动和混合拮抗的抑制和兴奋活性。咪唑可能是最有效的,具有最佳的中枢神经系统穿透性和活性特征,其次是咪唑并噻唑和苯并咪唑。
唑基团在所有这三类化合物中都很常见,可能是它们产生一些中枢神经系统效应的原因。所得化合物可能通过所有神经递质、电压门控和配体门控离子通道起作用,并且可能是手性的。